Maharashtra FDA Acts Against Cadila Pharma; Bars Sale Of Two Sets Of Medicines Over Brand Confusion

FDA Commissioner Tukaram Mundhe said confusion caused by similar brand names, which could lead doctors, pharmacists or patients to administer the wrong drug, amounted to a serious public health concern.